Remove 2016 Remove Medication Dispensing Remove Pharmaceutical Companies
article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

hit the rebate cap in 2016. With access to a wide range of specialty drugs and patient populations, these pharmacies can participate in drug trials — contributing to the advancement of medical knowledge, and the development of new treatment options. As we reported in a previous post , Humira , the top-selling drug in the U.S. ,

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

hit the rebate cap in 2016. With access to a wide range of specialty drugs and patient populations, these pharmacies can participate in drug trials — contributing to the advancement of medical knowledge, and the development of new treatment options. As we reported in a previous post , Humira , the top-selling drug in the U.S. ,

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

hit the rebate cap in 2016. With access to a wide range of specialty drugs and patient populations, these pharmacies can participate in drug trials — contributing to the advancement of medical knowledge, and the development of new treatment options. As we reported in a previous post , Humira , the top-selling drug in the U.S. ,